Loading
Latest filing published 24 Mar 2025 for IX BIOPHARMA LTD., €14k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Only one filing by Teo Woon Keng John is known so far (24 March 2025): an open-market purchase, €14k, in IX Biopharma Ltd. That is too little to draw conclusions. Every figure here comes from the filings published by SGX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration